restless legs syndrome

This page shows the latest restless legs syndrome news and features for those working in and with pharma, biotech and healthcare.

EC gives nod to restless leg syndrome drug Targin

EC gives nod to restless leg syndrome drug Targin. Mundipharma’ s medicine is first opioid granted a licence for condition in the EU. ... Mundipharma's Targin has been granted a licence in the EU for the treatment of restless leg syndrome (RLS).

Latest news

UCB names Jean-Christophe Tellier as Doliveux's successor

These include already-marketed drugs such as epilepsy therapy Vimpat (lacosamide) and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome (RLS), which are both growing quickly, as well as
Saatchi & Saatchi create Spanish restless legs syndrome campaign

Saatchi &Saatchi create Spanish restless legs syndrome campaign. Online public awareness push is in collaboration with UCB. ... of Restless Legs Syndrome, the Research Institute of Sleep, and Centro Comercial Príncipe Pío.
US shortage of GSK’s restless legs syndrome treatment Horizant

US shortage of GSK’ s restless legs syndrome treatment Horizant. FDA blames contract manufacturer delays. ... Delays at GlaxoSmithKline's (GSK) contract manufacturer have caused a shortage in the US of restless legs syndrome treatment Horizant,
Product updates from Japan

A flurry of new product approvals and filings in Japan includes drugs for pulmonary arterial hypertension, H pylori gastritis, Parkinson's/restless legs syndrome, breast cancer, carnitine deficiency and sedation during ... dentistry. Otsuka
Eliquis and Ryzodeg feature among Japan's year-end approvals

moderate-to-severe idiopathic restless legs syndrome in adults.

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Interview: Georg Toufar, Mundipharma

Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.
VIDEO interview: Neil Weir, UCB

epilepsy; and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

XenoPort appoints chief medical officer

Dr Kim has been with the US biopharma company since July 2013, when he joined as VP of medical affair, supporting the marketing of Horizant (gabapentin enacarbil) in restless legs syndrome

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director – Healthcare Advertising - London: Neg

Home based, Senior Medical Writer, Medical Communications: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Healthcare PR Director: £100, 000 – £120, 000 benefits

Client Services Director - Med Comms: Great salary and bebefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Manager: Competitive salary commensurate with experience

Home based, Principal Medical Writer, Medical Communications: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Account Manager: £40, 000 - £45, 000 benefits

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Home based, Editorial Team Leader, Medical Communications: Excellent package

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Business Unit Head, Medical Communications, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....